Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Ehsan Razeghian"'
Autor:
Mohaddeseh Rahbaran, Ehsan Razeghian, Marwah Suliman Maashi, Abduladheem Turki Jalil, Gunawan Widjaja, Lakshmi Thangavelu, Mariya Yurievna Kuznetsova, Pourya Nasirmoghadas, Farid Heidari, Faroogh Marofi, Mostafa Jarahian
Publikováno v:
Stem Cells International, Vol 2024 (2024)
Externí odkaz:
https://doaj.org/article/0a0795a9a6ec4e9f8c64e2ac5aec12b8
Autor:
Adel Naimi, Rebar N. Mohammed, Ahmed Raji, Supat Chupradit, Alexei Valerievich Yumashev, Wanich Suksatan, Mohammed Nader Shalaby, Lakshmi Thangavelu, Siavash Kamrava, Navid Shomali, Armin D. Sohrabi, Ali Adili, Ali Noroozi-Aghideh, Ehsan Razeghian
Publikováno v:
Cell Communication and Signaling, Vol 20, Iss 1, Pp 1-31 (2022)
Abstract The main breakthrough in tumor immunotherapy was the discovery of immune checkpoint (IC) proteins, which act as a potent suppressor of the immune system by a myriad of mechanisms. After that, scientists focused on the immune checkpoint molec
Externí odkaz:
https://doaj.org/article/a42a511ba4384466874a9dc6537c72e4
Autor:
Ehsan Razeghian, Mahyuddin K. M. Nasution, Heshu Sulaiman Rahman, Zhanna R. Gardanova, Walid Kamal Abdelbasset, Surendar Aravindhan, Dmitry O. Bokov, Wanich Suksatan, Pooria Nakhaei, Siavash Shariatzadeh, Faroogh Marofi, Mahboubeh Yazdanifar, Somayeh Shamlou, Roza Motavalli, Farhad Motavalli Khiavi
Publikováno v:
Stem Cell Research & Therapy, Vol 12, Iss 1, Pp 1-17 (2021)
Abstract To date, two chimeric antigen receptors (CAR)-T cell products from autologous T cells have been approved by The United States Food and Drug Administration (FDA). The case-by-case autologous T cell generation setting is largely considered as
Externí odkaz:
https://doaj.org/article/6754fa99391c491aaa671bc1441eb8c5
Autor:
Ehsan Razeghian, Wanich Suksatan, Heshu Sulaiman Rahman, Dmitry O. Bokov, Walid Kamal Abdelbasset, Ali Hassanzadeh, Faroogh Marofi, Mahboubeh Yazdanifar, Mostafa Jarahian
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
The immune cytokine tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has attracted rapidly evolving attention as a cancer treatment modality because of its competence to selectively eliminate tumor cells without instigating toxicity in
Externí odkaz:
https://doaj.org/article/a5f8302a8d1147d7b3bd2fe3bbe88337
Autor:
Ehsan Razeghian, Ria Margiana, Supat Chupradit, Dmitry O. Bokov, Walid Kamal Abdelbasset, Faroogh Marofi, Siavash Shariatzadeh, Foad Tosan, Mostafa Jarahian
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Pro-inflammatory cytokines can effectively be used for tumor immunotherapy, affecting every step of the tumor immunity cycle. Thereby, they can restore antigen priming, improve the effector immune cell frequencies in the tumor microenvironment (TME),
Externí odkaz:
https://doaj.org/article/94cd182116de4b82bac75c921d6a6a2a
Autor:
Mohaddeseh Rahbaran, Ehsan Razeghian, Marwah Suliman Maashi, Abduladheem Turki Jalil, Gunawan Widjaja, Lakshmi Thangavelu, Mariya Yurievna Kuznetsova, Pourya Nasirmoghadas, Farid Heidari, Faroogh Marofi, Mostafa Jarahian
Publikováno v:
Stem Cells International, Vol 2021 (2021)
Embryo splitting is one of the newest developed methods in reproductive biotechnology. In this method, after splitting embryos in 2-, 4-, and even 8-cell stages, every single blastomere can be developed separately, but the embryos are genetically ide
Externí odkaz:
https://doaj.org/article/e970a41346e649e0afe572ebbb853420
Autor:
Ali Hassanzadeh, Nasim Vousooghi, Ramin Rahimnia, Ehsan Razeghian, Simin Rajaeian, Iman Seyhoun, Shiva Sharif, Javad Verdi
Publikováno v:
Cell Biology International. 47:1033-1048
Autor:
Ehsan Razeghian, Mahdis Chahar Kameh, Sepehr Shafiee, Farima Khalafi, Fehimeh Jafari, Mohammadali Asghari, Kiarash Kazemi, Saba Ilkhani, Siavash Shariatzadeh, Arvin Haj-Mirzaian
Publikováno v:
Molecular Biology Reports. 49:10935-10948
The importance of the immune system on tumor surveillance has been investigated for many years, and its impact on controlling tumor progression has been verified. An important subgroup of the innate immune system is natural killer (NK) cells, whose e
Autor:
Firoozeh Abolhasani Zadeh, Mahsa Mardasi, Mohaddeseh Rahbaran, Sadegh Shojaei Baghini, Sahel Rahimi, Parastoo Tambrchi, Ehsan Razeghian
Publikováno v:
Annals of Cancer Research and Therapy. 30:22-27
Autor:
Mohaddeseh Rahbaran, Ehsan Razeghian
Publikováno v:
Annals of Cancer Research and Therapy. 29:55-61